A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Conditions:   CCND1 Positive;   Liver Lymphoma;   Mantle Cell Lymphoma;   t(11;14) Positive Interventions:   Drug: Acalabrutinib;   Drug: Bendamustine;   Drug: Bendamustine Hydrochloride;   Drug: Cytarabine;   Biological: Rituximab Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials